Doheny Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Doheny Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,695	Closed	-$326K	–	114
2017 Q1	$326K	Buy	+2,695	New	+$331K	0.15%	93
2016 Q3	–	Sell	-2,725	Closed	-$250K	–	109
2016 Q2	$250K	Buy	+2,725	New	+$229K	0.13%	92

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Doheny Asset Management's GWPH Position: Q2 2017 in Review

Doheny Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 2,695 shares — an estimated $326K sold.

Doheny Asset Management first reported a position in GWPH in Q2 2016 and held it in 2 quarters. The position peaked at $326K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

Doheny Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
Doheny Asset Management sold 2,695 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $326K.
Doheny Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 2 quarters.
Doheny Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $326K in Q1 2017.
170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Doheny Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.